WuXi Biologics (Cayman) Inc. (FRA:1FW2)
Germany flag Germany · Delayed Price · Currency is EUR
4.010
-0.090 (-2.20%)
Last updated: Jan 28, 2026, 8:05 AM CET

WuXi Biologics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
16,4838,96614,47630,34744,08444,275
Market Cap Growth
90.07%-38.06%-52.30%-31.16%-0.43%203.05%
Enterprise Value
16,0918,83514,21929,72242,86744,097
Last Close Price
4.012.173.367.20--
PE Ratio
33.0520.1933.3750.6193.99209.36
PS Ratio
6.923.636.6614.6530.9563.00
PB Ratio
2.831.492.586.189.7416.92
P/TBV Ratio
3.231.702.966.7910.5617.69
P/FCF Ratio
78.8352.62182.37---
P/OCF Ratio
24.2412.9924.3140.3792.82187.95
EV/Sales Ratio
6.793.586.5414.3530.1062.75
EV/EBITDA Ratio
19.5811.4222.6143.2285.50198.82
EV/EBIT Ratio
24.8214.5628.3450.3697.69234.41
EV/FCF Ratio
76.9551.85179.13---
Debt / Equity Ratio
0.100.110.100.120.130.16
Debt / EBITDA Ratio
0.730.820.890.861.181.85
Debt / FCF Ratio
2.903.847.33---
Asset Turnover
0.340.330.320.330.280.24
Inventory Turnover
6.366.715.044.313.944.15
Quick Ratio
2.401.982.351.561.852.49
Current Ratio
2.882.732.781.982.373.16
Return on Equity (ROE)
10.51%8.82%8.90%13.20%13.09%10.02%
Return on Assets (ROA)
5.89%5.05%4.63%5.81%5.43%4.03%
Return on Invested Capital (ROIC)
10.55%9.71%9.72%12.78%13.38%10.74%
Return on Capital Employed (ROCE)
10.60%9.50%8.00%10.80%8.90%6.10%
Earnings Yield
3.03%4.95%3.00%1.98%1.06%0.48%
FCF Yield
1.27%1.90%0.55%-0.15%-0.97%-1.17%
Buyback Yield / Dilution
2.55%2.80%0.62%1.04%-5.05%-5.30%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.